TRUXIMA

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug TRUXIMA contains one active pharmaceutical ingredient (API):

1	Rituximab UNII 4F4X42SYQ6 - RITUXIMAB
	Rituximab binds specifically to the transmembrane antigen, CD20, a non-glycosylated phosphoprotein, located on pre-B and mature B lymphocytes. The antigen is expressed on >95% of all B cell non-Hodgkin’s lymphomas.
	Read more about Rituximab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TRUXIMA Concentrate for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01FA01	Rituximab	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FA CD20 (Clusters of Differentiation 20) inhibitors
Discover more medicines within L01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10179R, 10193L, 10576P, 10583B, 10591K, 10593M, 11790M, 11800C, 11804G, 11805H, 11810N, 11813R, 11935E, 11936F, 4613T, 4614W, 4615X, 7257Y, 7258B, 7259C, 9544H, 9611W
BR	Câmara de Regulação do Mercado de Medicamentos	545120040000407, 545120040000507
CA	Health Products and Food Branch	02478382, 02478390
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	123-MBE-0218
EE	Ravimiamet	1739448, 1770993
ES	Centro de información online de medicamentos de la AEMPS	1161167001, 1161167002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	175351, 418667
FR	Base de données publique des médicaments	64102473, 64237955
GB	Medicines & Healthcare Products Regulatory Agency	341657, 346138
HK	Department of Health Drug Office	66443, 66444
IL	מִשְׂרַד הַבְּרִיאוּת	8342, 8343
IT	Agenzia del Farmaco	045266018, 045266020
LT	Valstybinė vaistų kontrolės tarnyba	1082365, 1085387
NL	Z-Index G-Standaard, PRK	51004, 51012
NZ	Medicines and Medical Devices Safety Authority	19626, 19647
PL	Rejestru Produktów Leczniczych	100387562, 100463050
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63707001, W63906001
SG	Health Sciences Authority	15671P
TR	İlaç ve Tıbbi Cihaz Kurumu	8680614140129, 8699862950244
US	FDA, National Drug Code	63459-103, 63459-104